| Report ID | 278729 |
| Drug Identification Number | 02499061 |
| Brand name | TARO-BORTEZOMIB |
| Common or Proper name | BORTEZOMIB |
| Company Name | TARO PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BORTEZOMIB |
| Strength(s) | 3.5MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS |
| Packaging size | 2.5mg Vial |
| Anatomical Therapeutical Chemical (ATC) code | L01XG |
| Anatomical Therapeutical Chemical (ATC) description | |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2026-02-01 |
| Estimated end date | 2026-04-27 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-02-23 |
| Company comments | Inventory is available with June 2026 dating |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-02-23 | French | Compare |
| v1 | 2026-02-23 | English | Compare |
Showing 1 to 2 of 2